- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
ETF Trends reported that most of the exchange-traded funds that achieved new all-time highs on Friday were related to the biotechnology sector.
ETF Trends reported that most of the exchange-traded funds that achieved new all-time highs on Friday were related to the biotechnology sector.
As quoted in the market news:
Today’s new all-time high club is comprised of four of the five major non-leveraged biotech ETFs, the ProShares Ultra Nasdaq Biotechnology (NasdaqGM: BIB), thedouble-leveraged equivalent of theiShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), and two other health care-related ETFs.
One of those other two ETFs is the PowerShares Dynamic Pharmaceuticals Portfolio (NYSEArca: PJP). Up about 0.8% today, PJP has not only hit a fresh all-time high, but the ETF is closing in on a weekly gain of nearly 6%. Not surprisingly, the ETF’s biotech exposure is proving rewarding.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.